These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22832527)

  • 1. Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genes.
    Mozhui K; Wang X; Chen J; Mulligan MK; Li Z; Ingles J; Chen X; Lu L; Williams RW
    Transl Psychiatry; 2011 Jul; 1(7):e25. PubMed ID: 22832527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.
    Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ
    Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
    Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL
    PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging.
    Jenkins AK; Paterson C; Wang Y; Hyde TM; Kleinman JE; Law AJ
    Mol Psychiatry; 2016 May; 21(5):701-6. PubMed ID: 26216298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
    Gauthier J; Siddiqui TJ; Huashan P; Yokomaku D; Hamdan FF; Champagne N; Lapointe M; Spiegelman D; Noreau A; Lafrenière RG; Fathalli F; Joober R; Krebs MO; DeLisi LE; Mottron L; Fombonne E; Michaud JL; Drapeau P; Carbonetto S; Craig AM; Rouleau GA
    Hum Genet; 2011 Oct; 130(4):563-73. PubMed ID: 21424692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings.
    Aksu Uzunhan T; Ayaz A
    Clin Neurol Neurosurg; 2022 Mar; 214():107141. PubMed ID: 35101781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-control association study of NRXN1 polymorphisms with schizophrenia in Chinese Han population.
    Yue W; Yang Y; Zhang Y; Lu T; Hu X; Wang L; Ruan Y; Lv L; Zhang D
    Behav Brain Funct; 2011 Apr; 7():7. PubMed ID: 21477380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models.
    Zeng L; Zhang P; Shi L; Yamamoto V; Lu W; Wang K
    PLoS One; 2013; 8(3):e59685. PubMed ID: 23536886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders.
    Hu Z; Xiao X; Zhang Z; Li M
    Mol Psychiatry; 2019 Oct; 24(10):1400-1414. PubMed ID: 31138894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence analysis of 17 NRXN1 deletions.
    Enggaard Hoeffding LK; Hansen T; Ingason A; Doung L; Thygesen JH; Møller RS; Tommerup N; Kirov G; Rujescu D; Larsen LA; Werge T
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):52-61. PubMed ID: 24339137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the neurexin 1 gene is associated with schizophrenia.
    Rujescu D; Ingason A; Cichon S; Pietiläinen OP; Barnes MR; Toulopoulou T; Picchioni M; Vassos E; Ettinger U; Bramon E; Murray R; Ruggeri M; Tosato S; Bonetto C; Steinberg S; Sigurdsson E; Sigmundsson T; Petursson H; Gylfason A; Olason PI; Hardarsson G; Jonsdottir GA; Gustafsson O; Fossdal R; Giegling I; Möller HJ; Hartmann AM; Hoffmann P; Crombie C; Fraser G; Walker N; Lonnqvist J; Suvisaari J; Tuulio-Henriksson A; Djurovic S; Melle I; Andreassen OA; Hansen T; Werge T; Kiemeney LA; Franke B; Veltman J; Buizer-Voskamp JE; ; Sabatti C; Ophoff RA; Rietschel M; Nöthen MM; Stefansson K; Peltonen L; St Clair D; Stefansson H; Collier DA
    Hum Mol Genet; 2009 Mar; 18(5):988-96. PubMed ID: 18945720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation screening of the neurexin 1 gene in thai patients with intellectual disability and autism spectrum disorder.
    Yangngam S; Plong-On O; Sripo T; Roongpraiwan R; Hansakunachai T; Wirojanan J; Sombuntham T; Ruangdaraganon N; Limprasert P
    Genet Test Mol Biomarkers; 2014 Jul; 18(7):510-5. PubMed ID: 24832020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurexin 1 variants as risk factors for suicide death.
    William N; Reissner C; Sargent R; Darlington TM; DiBlasi E; Li QS; Keeshin B; Callor WB; Ferris E; Jerominski L; Smith KR; Christensen ED; Gray DM; Camp NJ; Missler M; Williams ME; Coon H
    Mol Psychiatry; 2021 Dec; 26(12):7436-7445. PubMed ID: 34168285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review.
    Castronovo P; Baccarin M; Ricciardello A; Picinelli C; Tomaiuolo P; Cucinotta F; Frittoli M; Lintas C; Sacco R; Persico AM
    Clin Genet; 2020 Jan; 97(1):125-137. PubMed ID: 30873608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic modulators Nrxn1 and Nrxn3 are disregulated in a Disc1 mouse model of schizophrenia.
    Brown SM; Clapcote SJ; Millar JK; Torrance HS; Anderson SM; Walker R; Rampino A; Roder JC; Thomson PA; Porteous DJ; Evans KL
    Mol Psychiatry; 2011 Jun; 16(6):585-7. PubMed ID: 21321563
    [No Abstract]   [Full Text] [Related]  

  • 16. Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures.
    Lionel AC; Vaags AK; Sato D; Gazzellone MJ; Mitchell EB; Chen HY; Costain G; Walker S; Egger G; Thiruvahindrapuram B; Merico D; Prasad A; Anagnostou E; Fombonne E; Zwaigenbaum L; Roberts W; Szatmari P; Fernandez BA; Georgieva L; Brzustowicz LM; Roetzer K; Kaschnitz W; Vincent JB; Windpassinger C; Marshall CR; Trifiletti RR; Kirmani S; Kirov G; Petek E; Hodge JC; Bassett AS; Scherer SW
    Hum Mol Genet; 2013 May; 22(10):2055-66. PubMed ID: 23393157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurexins.
    Reissner C; Runkel F; Missler M
    Genome Biol; 2013; 14(9):213. PubMed ID: 24083347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response.
    Souza RP; Meltzer HY; Lieberman JA; Le Foll B; Kennedy JL
    Hum Psychopharmacol; 2010 Nov; 25(7-8):582-5. PubMed ID: 20860064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids.
    Sebastian R; Jin K; Pavon N; Bansal R; Potter A; Song Y; Babu J; Gabriel R; Sun Y; Aronow B; Pak C
    Nat Commun; 2023 Jun; 14(1):3770. PubMed ID: 37355690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter-like sequences regulating transcriptional activity in neurexin and neuroligin genes.
    Runkel F; Rohlmann A; Reissner C; Brand SM; Missler M
    J Neurochem; 2013 Oct; 127(1):36-47. PubMed ID: 23875667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.